Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Anticancer Research|April 3, 2020
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer SubtypesReiko Fukui, Yukie Fujimoto, Takahiro Watanabe, et al.
European Journal of Radiology|May 1, 2016
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinomaKazuhiro Kitajima, Toshiko Yamano, Kazuhito Fukushima, et al.
Cancer Science|November 15, 2019
Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancerYukie Fujimoto, Natsuko Inoue, Koji Morimoto, et al.
Annals of Surgical Oncology|April 4, 2019
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in <sup>18</sup>F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative ChemotherapyTomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, et al.
Anticancer Research|October 3, 2022
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 InhibitorHiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, et al.
International Journal of Oncology|January 3, 2020
The GALNT6‑LGALS3BP axis promotes breast cancer cell growthRyuichiro Kimura, Tetsuro Yoshimaru, Yosuke Matsushita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancersYasuo Miyoshi, Seung Jin Kim, Kenji Akazawa, et al.
International Journal of Clinical Oncology|December 19, 2013
Development of an integrated support system for hereditary cancer and its impact on gynecologic servicesMina Morii-Kashima, Hiroshi Tsubamoto, Chika Sato, et al.
Clinical Breast Cancer|April 2, 2018
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-PaclitaxelYoshimasa Miyagawa, Kazuhiro Araki, Ayako Bun, et al.
International Journal of Clinical Oncology|April 28, 2025
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecanYusa Togashi, Masayuki Nagahashi, Aoi Oshiro, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Anticancer Research|April 3, 2020
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer SubtypesReiko Fukui, Yukie Fujimoto, Takahiro Watanabe, et al.
European Journal of Radiology|May 1, 2016
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinomaKazuhiro Kitajima, Toshiko Yamano, Kazuhito Fukushima, et al.
Cancer Science|November 15, 2019
Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancerYukie Fujimoto, Natsuko Inoue, Koji Morimoto, et al.
Annals of Surgical Oncology|April 4, 2019
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in <sup>18</sup>F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative ChemotherapyTomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, et al.
Anticancer Research|October 3, 2022
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 InhibitorHiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, et al.
International Journal of Oncology|January 3, 2020
The GALNT6‑LGALS3BP axis promotes breast cancer cell growthRyuichiro Kimura, Tetsuro Yoshimaru, Yosuke Matsushita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancersYasuo Miyoshi, Seung Jin Kim, Kenji Akazawa, et al.
International Journal of Clinical Oncology|December 19, 2013
Development of an integrated support system for hereditary cancer and its impact on gynecologic servicesMina Morii-Kashima, Hiroshi Tsubamoto, Chika Sato, et al.
Clinical Breast Cancer|April 2, 2018
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-PaclitaxelYoshimasa Miyagawa, Kazuhiro Araki, Ayako Bun, et al.
International Journal of Clinical Oncology|April 28, 2025
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecanYusa Togashi, Masayuki Nagahashi, Aoi Oshiro, et al.
Pageof 18